Literature DB >> 16118535

Early-stage and preclinical Alzheimer disease.

John C Morris.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16118535     DOI： 10.1097/01.wad.0000184005.22611.cc

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  64 in total

1.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Ana Espinosa; Sergi Valero; Isabel Hernández; Agustín Ruíz; James T Becker; Maitée Rosende-Roca; Ana Mauleón; Oscar Sotolongo; Joan Castell-Conesa; Isabel Roca; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.

Authors:  Marta Cosín-Tomás; Anna Antonell; Albert Lladó; Daniel Alcolea; Juan Fortea; Mario Ezquerra; Albert Lleó; Maria José Martí; Mercè Pallàs; Raquel Sanchez-Valle; José Luís Molinuevo; Coral Sanfeliu; Perla Kaliman
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

4.  Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease.

Authors:  R S Desikan; L K McEvoy; D Holland; W K Thompson; J B Brewer; P S Aisen; O A Andreassen; B T Hyman; R A Sperling; A M Dale
Journal:  AJNR Am J Neuroradiol       Date:  2012-09-13       Impact factor: 3.825

5.  Association Between Sleep Characteristics and Incident Dementia Accounting for Baseline Cognitive Status: A Prospective Population-Based Study.

Authors:  Kathleen Bokenberger; Peter Ström; Anna K Dahl Aslan; Anna L V Johansson; Margaret Gatz; Nancy L Pedersen; Torbjörn Åkerstedt
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-07-11       Impact factor: 6.053

6.  Population Normative Data for the CERAD Word List and Victoria Stroop Test in Younger- and Middle-Aged Adults: Cross-Sectional Analyses from the Framingham Heart Study.

Authors:  Lisa D Hankee; Sarah R Preis; Ryan J Piers; Alexa S Beiser; Sherral A Devine; Yulin Liu; Sudha Seshadri; Philip A Wolf; Rhoda Au
Journal:  Exp Aging Res       Date:  2016 Jul-Sep       Impact factor: 1.645

7.  Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.

Authors:  Adam P Ingber; Jason Hassenstab; Anne M Fagan; Tammie L S Benzinger; Elizabeth A Grant; David M Holtzman; John C Morris; Catherine M Roe
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

8.  Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.

Authors:  Annie M Racine; Rebecca L Koscik; Sara E Berman; Christopher R Nicholas; Lindsay R Clark; Ozioma C Okonkwo; Howard A Rowley; Sanjay Asthana; Barbara B Bendlin; Kaj Blennow; Henrik Zetterberg; Carey E Gleason; Cynthia M Carlsson; Sterling C Johnson
Journal:  Brain       Date:  2016-06-20       Impact factor: 13.501

9.  Longitudinal Assessment of Self- and Informant-Subjective Cognitive Complaints in a Sample of Healthy Late-Middle Aged Adults Enriched with a Family History of Alzheimer's Disease.

Authors:  Christopher R Nicholas; N Maritza Dowling; Annie M Racine; Lindsay R Clark; Sara E Berman; Rebecca L Koscik; Sanjay Asthana; Bruce Hermann; Mark A Sager; Sterling C Johnson
Journal:  J Int Neuropsychol Soc       Date:  2017-07-11       Impact factor: 2.892

Review 10.  Recent Progress in the Pharmacotherapy of Alzheimer's Disease.

Authors:  Rita Khoury; Kush Patel; Jake Gold; Stephanie Hinds; George T Grossberg
Journal:  Drugs Aging       Date:  2017-11       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.